A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients. (JoHFR)

July 18, 2024 updated by: Hadi Abu-Hantash, Jordan Cardio Vascular Research Group

The Jordanian Heart Failure Registry (JoHFR)

Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Other: observational

Detailed Description

Understanding the cause of Heart Failure (HF) and how the body will respond to it, is critical for an effective treatment. HF is a global problem with significant morbidity and mortality, despite improved understanding of the pathophysiology and a growing range of therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research project of heart failure prevalence in Jordan. It is undertaken by primary healthcare professionals with main aim to improve knowledge about the care of patients with HF. The investigators responsible for conducting this research are physicians and their teams who deal with heart failure patients in their outpatient and inpatient clinic centers including the public and private medical sectors in Jordan's medical community. Standards in the Hashemite kingdom of Jordan complies with the recognized good guideline directed medical practices internationally

Study Type

Observational

Enrollment (Actual)

2219

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Jordan
- - Amman, Jordan, 11180
    - Farah Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

patients 18 years old and older with HF will be recruited from all over Jordan , resulting in an initial sample estimate of approximately 4000 patients.

Description

Inclusion Criteria:

Patients who are 18 years or older with Heart Failure diagnosis as defined by internationally recognized guidelines.
Current residents of the Hashemite Kingdom of Jordan

Exclusion Criteria:

Patients who refuse or unable to sign a consent form.
Patient inability to follow up with provider

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Observational Models: Cohort
Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cardiovascular death Time Frame: 12 months	The main objective of the JoHFR is to obtain reliable estimate of rates of cardiovascular death and or hospitalization for decompensated heart failure	12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
worsening kidney function Time Frame: 12 months	as compared to baseline eGFR	12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jordan Cardio Vascular Research Group

Investigators

Study Chair: Hadi M Abu-Hantash, MD,MSc, Interventional Cardiovascular Innovation group

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

December 30, 2023

Study Completion (Actual)

December 30, 2023

Study Registration Dates

First Submitted

March 31, 2021

First Submitted That Met QC Criteria